Skip to content
Governance Register

← US public companies

Neos Therapeutics, Inc.

SEC CIK 1467652 · NEOS · last insider filing 2021-03-19

Directors (from insider filings)

NameCapacity as filedFilings
Heller Alan L Director filed 2015 - 2021
Robitaille Gregory J Director filed 2015 - 2021
Schmid John P. Director filed 2015 - 2021
Mclaughlin Gerald W. Director · Chief Executive Officer filed 2018 - 2021
Fong Bryant Director filed 2015 - 2021
Hecht Beth Director filed 2015 - 2021
Robinson James A. Jr. Director filed 2019 - 2021
Szyper Linda M Director filed 2018 - 2021
Garg Vipin K Director · President, CEO & Director filed 2015 - 2018
Edick Paul R Director filed 2015 - 2017

Officers (from insider filings)

NameTitle as filedFilings
Limongelli John M SVP & General Counsel filed 2019 - 2021
Eisenstadt Richard I Chief Financial Officer filed 2015 - 2021
Mcdonnell Thomas P Chief Commercial Officer filed 2015 - 2018
Engelking Dorothy VP, Regulatory Affairs filed 2015 - 2018
Martens Juergen Chief Tech/Operations Officer filed 2016 - 2017
Tengler Mark Chief Technology Officer filed 2015 - 2015

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.